Company Deep Dive

Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.

Request Deep Dive(50 Feathers)

002821.SZ

STRONG BUYFLAG

Asymchem Laboratories (Tianjin) Co., Ltd. · Healthcare · China · $6.3B · Avg Vol: $115M/d

83
StockRank
Q
65
V
30
M
75
P/E (TTM)
36.5x
ROE
6.3%
D/E
0.0x
Dividend %
1.1%
AI CONVICTION THESIS

Asymchem is a leading CDMO with strong technical capabilities. While it fits the CDMO pricing power theme, it faces severe geopolitical headwinds from Western legislative efforts (such as the US Biosecure Act) targeting Chinese biotech partners.

COMPANY DESCRIPTION

Asymchem Laboratories (Tianjin) Co., Ltd. is a leading global contract development and manufacturing organization (CDMO) providing customized services for the pharmaceutical industry. The company specializes in small molecule drug development and commercial manufacturing, utilizing advanced continuous flow chemistry and green manufacturing technologies. It maintains a strong competitive position through long-term partnerships with global multinational pharmaceutical companies and high-quality regulatory compliance.

FINANCIAL SUMMARY (USD)

Year2022202320242025CAGR
Revenue1.5B1.2B858M986M-13.4%
EPS1.330.930.400.47-29.5%
Shares370M370M368M361M-2.5%
Debt20M22M48M46M30.7%
Equity2.3B2.6B2.5B2.6B4.1%
Op CF486M525M185M208M-24.6%
Inv CF-690M-398M-175M-94M
Fin CF-110M-80M-285M-51M
Loading...
PRICE (1M)-0.3%
16.2216.9717.7218.4719.22May 8May 29Jun 18
SMA 50SMA 200
Close
$18.21
RSI (14)
57.4
52W High
$19.65
From 52W High
0.9%

SCORE BREAKDOWN

Quality
65
ROIC
7.1%63.5
ROE
6.3%59.8
GP/Assets
14.2%33.5
Op. Margin
22.3%85.6
FCF/Assets
-0.9%47.0
Piotroski
83.4
Int. Cover
50.0x91.5
D/E Ratio
0.02x84.5
Current Ratio
5.69x74.5
Value
30
P/E (TTM)
36.5x29.7
EV/EBITDA
21.0x17.4
P/FCF
N/A
P/B
2.3x50.1
P/S
5.9x36.1
Div Yield
1.1%30.7
Momentum
75
52W High %
93%91.5
RS 6M
23%88.0
SMA 50/200
1.13x83.9
EPS Rev 4W
N/A
EPS Rev 12W
N/A
EPS Improve
+58%57.8
Q Growth
-7%35.0

FUNDAMENTALS

Market Cap
$6.3B
P/E (Forward)
23.1x
Gross Margin
41.3%

SECTOR PEERS

Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of 002821.SZ are excluded.

TickerCompanyMkt CapStockRankSignal
002821.SZAsymchem Laboratories (Tianjin) Co., Ltd.(you)$6.3B83STRONG BUY
688336.SSSunshine Guojian Pharmaceutical (Shanghai) Co., Ltd$5.9B82STRONG BUY
688578.SSShanghai Allist Pharmaceuticals Co., Ltd.$6.0B94STRONG BUY
1530.HK3SBio Inc.$5.9B96STRONG BUY
002007.SZHualan Biological Engineering Inc.$3.7B78BUY
2269.HKWuXi Biologics (Cayman) Inc.$17.6B87STRONG BUY
300009.SZAnhui Anke Biotechnology (Group) Co., Ltd.$2.1B85STRONG BUY
3759.HKPharmaron Beijing Co., Ltd.$4.1B60HOLD
002653.SZHaisco Pharmaceutical Group Co., Ltd.$8.5B56HOLD
688278.SSXiamen Amoytop Biotech Co., Ltd.$3.4B57HOLD

Peer medians: ROE 4.7% · P/E 27.8x · Gross margin 53.2%

Asymchem Laboratories (Tianjin) Co., Ltd. (002821.SZ) — Stock Score Summary

Asymchem Laboratories (Tianjin) Co., Ltd. (002821.SZ) has a MoatMap StockRank of 83/100 based on Quality (65/100), Value (30/100), and Momentum (75/100) factor scores. The current signal is STRONG BUY. Asymchem is a leading CDMO with strong technical capabilities. While it fits the CDMO pricing power theme, it faces severe geopolitical headwinds from Western legislative efforts (such as the US Biosecure Act) targeting Chinese biotech partners.

Asymchem Laboratories (Tianjin) Co., Ltd. is a leading global contract development and manufacturing organization (CDMO) providing customized services for the pharmaceutical industry. The company specializes in small molecule drug development and commercial manufacturing, utilizing advanced continuous flow chemistry and green manufacturing technologies. It maintains a strong competitive position through long-term partnerships with global multinational pharmaceutical companies and high-quality regulatory compliance.

Key Financial Metrics

Price$18.21
Market Cap$6.3B
P/E (TTM)36.52
P/E (Forward)23.14
Price/Book2.29
Return on Equity6.3%
Return on Invested Capital7.1%
Debt/Equity1.63
Gross Margin41.3%
Operating Margin22.3%
Revenue Growth16.9%
Dividend Yield1.1%
Free Cash Flow$-4M

Asymchem Laboratories (Tianjin) Co., Ltd. operates in the Biotechnology industry, part of the Healthcare sector (China).

Frequently Asked Questions

What is Asymchem Laboratories (Tianjin) Co., Ltd.’s (002821.SZ) StockRank?
MoatMap’s StockRank for Asymchem Laboratories (Tianjin) Co., Ltd. (002821.SZ) is 83/100, with a Strong Buy signal. It is a composite of Quality (65), Value (30), and Momentum (75) factor ranks across MoatMap’s 20,000+ stock universe.
Does Asymchem Laboratories (Tianjin) Co., Ltd. have an economic moat?
Asymchem Laboratories (Tianjin) Co., Ltd. (002821.SZ) has a Quality factor score of 65/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Asymchem Laboratories (Tianjin) Co., Ltd. a buy, hold, or sell?
MoatMap’s current signal for Asymchem Laboratories (Tianjin) Co., Ltd. (002821.SZ) is Strong Buy, based on a StockRank of 83/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Asymchem Laboratories (Tianjin) Co., Ltd. in?
Asymchem Laboratories (Tianjin) Co., Ltd. (002821.SZ) operates in the Healthcare sector, specifically the Biotechnology industry (China).